NeoSense_1062 is a seed startup based in France. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
NeoSense develops a non-invasive medical device for the continuous monitoring of cerebral blood flow in newborns, aiming to detect and prevent brain damage.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky